Long Shortz: Challenger Gold
Challenger Gold signs IPA with Ecuadorean government to safeguard its investment into the El Guayabo project.
Challenger Gold signs IPA with Ecuadorean government to safeguard its investment into the El Guayabo project.
Tryptamine Therapeutics has appointed global pharmaceutical leader Herwig Janssen as its new non-executive chairman.
Andromeda Metals’ $5m placement will advance its Great White kaolin and HPA projects.
Orthocell has been given the green light to sell its flagship nerve-repair product Remplir in the strategically important Hong Kong market.
ASX tech found its rhythm in April as rate cut hopes and Wall Street gave it a lift; WhiteHawk and Elsight stole the defence show.
Delta Lithium is demerging its Mt Ida gold project after boosting resources by 46% to 1.1Moz.
Buxton Resources has announced a $3 million placement and EIS grant for its Madman and Centurion projects.
Host Guy Le Page puts gold developer and explorer Koonenberry Gold under the microscope as the yellow metal trades ever higher.
Albo has clinched the election, and with fresh plans on housing, climate and critical minerals, investors are already sizing up the next move.
History shows the share market is most likely to rise in the months after a federal election, with downturns usually caused by offshore factors.
The ASX kept climbing as CBA hit a new high, US tech stayed wobbly, and whispers of a US-China trade thaw helped copper bounce back.
With its eyes fixed on the US and its strategy to develop a domestic minerals supply chain, Dateline Resources is strengthening US ties and engagement.
The ASX has notched a more than 1pc gain with strong performances across the board to post a seventh straight day in the green.
These sub-$10m stocks could be poised to make gains as the gold price busts the US$3000/oz ceiling.
Original URL: https://www.goldcoastbulletin.com.au/business/stockhead/page/20